No matter how bad things might seem, at least you haven't accidentally eaten fox poop and developed an insidious tapeworm ...

The family of a young dad living with terminal brain cancer has welcomed groundbreaking research that could revolutionise ...

A promising new study is changing the way doctors think about treating certain cancers. The research focuses on immunotherapy ...

The FDA has granted fast-track approval to the drug telisotuzumab vedotin (sold as Emrelis) as a first-of-its-kind treatment for certain people who have non-squamous non-small-cell lung cancer.

The FDA approved retifanlimab (Zynyz; Incyte) as the first and only first-line treatment for advanced anal cancer, supported ...

The U.S. Food and Drug Administration said on Wednesday it has approved the expanded use of Merck's cancer drug to treat two ...

Researchers from A*STAR Institute of Molecular and Cell Biology (A*STAR IMCB) and local biotechnology company Intra-ImmuSG ...

Cryptic peptides, which are expressed in pancreatic cancer cells, could be promising targets for T-cell therapies that attack pancreatic tumors, according to a new study.

Cancer treatment with a cell-based immunotherapy causes mild cognitive impairment, a Stanford Medicine team found. They also identified compounds that could treat it. After treatment with CAR-T ...

Over 100 golfers including cancer survivors will converge on the Ikoyi Golf Club on Thursday, May 8, to raise awareness for cancer prevention at the Foundation for Cancer Care’s annual charity ...